Ultimately, however, they suggest that the regulation of these melanoma-promoting genes by FTO and other proteins might critically affect gene expression in melanoma (e.g., the methyltransferases METTL3 and METTL14) and further studies on the therapeutic potential of such are warranted. The gene discussed is METTL14; the disease is melanoma.